Invasive Haemophilus influenzae Disease in Alaskan Residents Aged 10 Years and Older Before and After Infant Vaccination Programs
CONTEXT The introduction of Haemophilus influenzae type b (Hib) vaccination of children has led to a decline in incidence of Hib disease in young Alaskan children. However, the impact of vaccination on unimmunized Alaskan adolescents and adults has not been studied. OBJECTIVE To characterize trends...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2000-06, Vol.283 (23), p.3089-3094 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | CONTEXT The introduction of Haemophilus influenzae
type b (Hib) vaccination of children has led to a decline in incidence of
Hib disease in young Alaskan children. However, the impact of vaccination
on unimmunized Alaskan adolescents and adults has not been studied. OBJECTIVE To characterize trends in incidence of and mortality due to invasive H influenzae disease in Alaskan residents aged 10 years
and older prior to and after the introduction of a statewide Hib infant vaccination
program. DESIGN AND SETTING Population-based, descriptive correlational study conducted 1980-1996
in Alaska. SUBJECTS One hundred twenty-nine individuals (31 Alaska Natives and 98 nonnative
Alaska residents) aged 10 years and older in whom H influenzae was cultured from a normally sterile site. MAIN OUTCOME MEASURES Incidence of H influenzae infection before
(1980-1990) vs after (1991-1996) vaccination program initiation; serotype,
biotype, and β-lactamase production of isolates. RESULTS The overall annual incidence of invasive H influenzae in those aged 10 years and older declined 33%, from 2.1 per 100,000
persons per year to 1.4 per 100,000 persons per year (P=.03) after initiation of statewide infant Hib vaccination programs
in 1991. This reduction appeared to be the result of a decrease in serotype
b disease (82%; P |
---|---|
ISSN: | 0098-7484 1538-3598 |
DOI: | 10.1001/jama.283.23.3089 |